Cover Image

An overview of methods for receiver operating characteristic analysis, with an application to SARS-CoV-2 vaccine-induced humoral responses in solid organ transplant recipients

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Dowd, Nathaniel P., Blette, Bryan, Chappell, James D., Halasa, Natasha B., Spieker, Andrew J.
Format:	Preprint
Published:	2024
Subjects:	Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine
by: Cinzia Borgogna, et al.
Published: (2024)

Anti‐spike antibody durability after SARS‐CoV‐2 vaccination in adolescent solid organ transplant recipients
by: John McAteer, et al.
Published: (2024)

Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study
by: Judit Cacho, et al.
Published: (2025)

Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey
by: Alessandro Visentin, et al.
Published: (2024)

Chromomycosis in solid organ transplant recipients
by: Isadora Zago Miotto, et al.
Published: (2024)

Blood donor SARS‐CoV‐2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients
by: Nareg H. Roubinian, et al.
Published: (2025)

Safety of anidulafungin in solid organ transplant recipients
by: Aguado, J.M., et al.
Published: (2012)

Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses
by: Li Song, et al.
Published: (2025)

Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis
by: Isabel S. Griffin, et al.
Published: (2024)

A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation
by: Jan Van Slambrouck, et al.
Published: (2024)

Use of biologics for psoriasis in solid organ transplant recipients
by: Marta Costa Blasco, et al.
Published: (2024)

PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses
by: Dennis Horvath, et al.
Published: (2026)

Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention?
by: Alyssa Pradhan, et al.
Published: (2024)

Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
by: B. Levian, et al.
Published: (2024)

Clinical outcomes of SARS‐CoV‐2 infection in kidney transplant recipients on belatacept: a single‐center experience
by: Fionna Feller, et al.
Published: (2024)

Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
by: Jennifer L. Alejo, et al.
Published: (2024)

Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
by: Emily Eribes, et al.
Published: (2024)

Sex differences in cancer mortality among solid organ transplant recipients
by: Sarah S. Jackson, et al.
Published: (2025)

Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
by: Nicole L Messina, et al.
Published: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors
by: Thomas Lynes, et al.
Published: (2024)

Monte Carlo simulation of SARS-CoV-2 radiation-induced inactivation for vaccine development
by: Francis, Ziad, et al.
Published: (2020)

Safety and immunogenicity of vaccines against SARS-CoV-2
by: Francisco Xavier Poveda Paredes
Published: (2021)

Biological characteristics of SARS-CoV-2 variants of epidemiological interest and their impact on vaccine efficacy and effectiveness.
by: Torres, Carolina, et al.
Published: (2021)

Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
by: Eva Tranter, et al.
Published: (2024)

Transfusion requirements in recipients of plasma units from blood donors with recent SARS ‐ CoV ‐2 infection
by: Nareg H. Roubinian, et al.
Published: (2026)

Incidence of biliary atresia in the United States before and during the COVID‐19 pandemic
by: Yasmeen Z. Qwaider, et al.
Published: (2025)

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients
by: Sergio A. Acuna, et al.
Published: (2026)

Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant
by: Taylor Heald‐Sargent, et al.
Published: (2024)

The characteristics of BCR‐CDR3 repertoire in COVID‐19 patients and SARS‐CoV‐2 vaccinated volunteers
by: Jiaping Xiao, et al.
Published: (2024)

Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients
by: Takaaki Ono, et al.
Published: (2026)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
by: Fredrika Hellgren, et al.
Published: (2026)

Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
by: Zheng Quan Toh, et al.
Published: (2024)

Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
by: Jessica Hedvat, et al.
Published: (2024)

Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin
by: Rebecca Rojansky, et al.
Published: (2024)

Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell‐mediated immune assays
by: Vivek B. Beechar, et al.
Published: (2024)

Clinical overview for pediatric population with SARS-CoV-2 and care: review
by: Martins, Lucas Amaral, et al.
Published: (2021)

Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
by: William Mouton, et al.
Published: (2024)

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease
by: Arthur J. Kastl, et al.
Published: (2024)